Welcome to LookChem.com Sign In|Join Free
  • or
5-(Benzyloxy)-4-chloropyriMidine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

91063-23-9

Post Buying Request

91063-23-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

91063-23-9 Usage

Uses

5-(Benzyloxy)-4-chloropyrimidine is a precursor to many other hydroxypyrimidine.

Check Digit Verification of cas no

The CAS Registry Mumber 91063-23-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,0,6 and 3 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 91063-23:
(7*9)+(6*1)+(5*0)+(4*6)+(3*3)+(2*2)+(1*3)=109
109 % 10 = 9
So 91063-23-9 is a valid CAS Registry Number.

91063-23-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-chloro-5-phenylmethoxypyrimidine

1.2 Other means of identification

Product number -
Other names 5-Benzyloxy-4-chlor-pyrimidin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:91063-23-9 SDS

91063-23-9Downstream Products

91063-23-9Relevant academic research and scientific papers

STEROID SPARING AGENTS AND METHODS OF USING SAME

-

Page/Page column 560, (2010/02/14)

This invention relates generally to the use of a steroid sparing agent for the preparation of a medicament for the treatment of inflammatory bowel diseases (IBD), asthma, multiple sclerosis (MS), rheumatoid arthritis (RA), graft versus host disease (GVHD), host versus graft disease, and various spondyloarthropathies, comprising administering a steroid sparing immunoglobulin or small molecule composition to a patient in need thereof. The invention also relates generally to combination therapies for the treatment of these conditions.

Uracil compounds and use thereof

-

, (2008/06/13)

The present invention relates to an uracil compound of the formula [I]: [wherein, Q—R3represents a R3-substituted group of a 5-membered or 6-membered heterocyclic ring having one or two nitrogen selected from the group consisting of

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 91063-23-9